argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
829.83
+12.51 (1.53%)
At close: Oct 27, 2025, 4:00 PM EDT
817.21
-12.62 (-1.52%)
After-hours: Oct 27, 2025, 7:47 PM EDT
argenx SE Market Cap
argenx SE has a market cap or net worth of $50.6 billion as of October 27, 2025. Its market cap has increased by 60.51% in one year.
Market Cap
50.60B
Enterprise Value
46.75B
1-Year Change
60.51%
Ranking
Category
Stock Price
$829.83
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $50.60B, an increase of 8,088.27%. That is a compound annual growth rate of 68.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 50.65B | 37.73% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
| May 18, 2017 | 618.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |